{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:47:43Z","timestamp":1791359263207,"version":"4.3.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02181-3","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:47:08Z","timestamp":1743259628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Global trends in esophageal cancer and metabolic syndrome research: bibliometric analysis and visualization from 1995 to 2024"],"prefix":"10.1007","volume":"16","author":[{"given":"Peng-Yu","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jian","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"3","key":"2181_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2181_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cancers13010141","volume":"13","author":"J Huang","year":"2021","unstructured":"Huang J, Koulaouzidis A, Marlicz W, Lok V, Chu C, Ngai CH, et al. Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries. Cancers. 2021;13(1):141. https:\/\/doi.org\/10.3390\/cancers13010141.","journal-title":"Cancers"},{"issue":"3","key":"2181_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649-658.e2. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.054.","journal-title":"Gastroenterology"},{"issue":"9","key":"2181_CR4","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/cancers13092183","volume":"13","author":"E Marabotto","year":"2021","unstructured":"Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, et al. Prevention strategies for esophageal cancer-an expert review. Cancers. 2021;13(9):2183. https:\/\/doi.org\/10.3390\/cancers13092183.","journal-title":"Cancers"},{"issue":"8","key":"2181_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042281","volume":"7","author":"JB Wang","year":"2012","unstructured":"Wang JB, Fan JH, Liang H, Li J, Xiao HJ, Wei WQ, et al. Attributable causes of esophageal cancer incidence and mortality in China. PLoS ONE. 2012;7(8): e42281. https:\/\/doi.org\/10.1371\/journal.pone.0042281.","journal-title":"PLoS ONE"},{"issue":"5","key":"2181_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/aje\/kwr117","volume":"174","author":"CM Olsen","year":"2011","unstructured":"Olsen CM, Pandeya N, Green AC, Webb PM, Whiteman DC, Australian Cancer Study. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am J Epidemiol. 2011;174(5):582\u201390. https:\/\/doi.org\/10.1093\/aje\/kwr117.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2181_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469\u201380. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x.","journal-title":"Diabet Med"},{"issue":"12","key":"2181_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2174\/1871530323666230309144825","volume":"23","author":"K Madan","year":"2023","unstructured":"Madan K, Paliwal S, Sharma S, Kesar S, Chauhan N, Madan M. Metabolic syndrome: the constellation of co-morbidities, a global threat. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1491\u2013504. https:\/\/doi.org\/10.2174\/1871530323666230309144825.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"2181_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.metabol.2014.10.008","volume":"64","author":"FM Mendon\u00e7a","year":"2015","unstructured":"Mendon\u00e7a FM, de Sousa FR, Barbosa AL, Martins SC, Ara\u00fajo RL, Soares R, et al. Metabolic syndrome and risk of cancer: which link? Metabolism. 2015;64(2):182\u20139. https:\/\/doi.org\/10.1016\/j.metabol.2014.10.008.","journal-title":"Metabolism"},{"issue":"3","key":"2181_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12253-015-9913-z","volume":"21","author":"JV Fernandes","year":"2015","unstructured":"Fernandes JV, Cobucci RN, Jatob\u00e1 CA, Fernandes TA, de Azevedo JW, de Ara\u00fajo JM. The role of the mediators of inflammation in cancer development. Pathol Oncol Res. 2015;21(3):527\u201334. https:\/\/doi.org\/10.1007\/s12253-015-9913-z.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"2181_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13098-024-01335-7","volume":"16","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huang C, Xu M. Influence of metabolic syndrome on prognosis of patients with surgically treated esophageal cancer: a meta-analysis. Diabetol Metab Syndr. 2024;16(1):111. https:\/\/doi.org\/10.1186\/s13098-024-01335-7.","journal-title":"Diabetol Metab Syndr"},{"key":"2181_CR12","doi-asserted-by":"publisher","first-page":"627270","DOI":"10.3389\/fonc.2021.627270","volume":"11","author":"JA Elliott","year":"2021","unstructured":"Elliott JA, Reynolds JV. Visceral obesity, metabolic syndrome, and esophageal adenocarcinoma. Front Oncol. 2021;11:627270. https:\/\/doi.org\/10.3389\/fonc.2021.627270.","journal-title":"Front Oncol"},{"key":"2181_CR13","doi-asserted-by":"publisher","first-page":"154955","DOI":"10.1016\/j.metabol.2021.154955","volume":"127","author":"Z Liu","year":"2022","unstructured":"Liu Z, Lin C, Suo C, Zhao R, Jin L, Zhang T, et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022;127:154955. https:\/\/doi.org\/10.1016\/j.metabol.2021.154955.","journal-title":"Metabolism"},{"issue":"4","key":"2181_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/jgh.16477","volume":"39","author":"ZQ Zhan","year":"2024","unstructured":"Zhan ZQ, Chen YZ, Huang ZM, Luo YH, Zeng JJ, Wang Y, et al. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study. J Gastroenterol Hepatol. 2024;39(4):630\u201341. https:\/\/doi.org\/10.1111\/jgh.16477.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2181_CR15","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1097\/JS9.0000000000000492","volume":"109","author":"S Jiang","year":"2023","unstructured":"Jiang S, Liu Y, Zheng H, Zhang L, Zhao H, Sang X, et al. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. Int J Surg. 2023;109(9):2774\u201383. https:\/\/doi.org\/10.1097\/JS9.0000000000000492.","journal-title":"Int J Surg"},{"key":"2181_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NK Van Eck","year":"2010","unstructured":"Van Eck NK, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523\u20138. https:\/\/doi.org\/10.1007\/s11192-009-0146-3.","journal-title":"Scientometrics"},{"key":"2181_CR17","first-page":"724","volume":"2005","author":"MB Synnestvedt","year":"2005","unstructured":"Synnestvedt MB, Chen CM, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724\u20138.","journal-title":"AMIA Annu Symp Proc"},{"key":"2181_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.joi.2018.03.005","volume":"12","author":"X Pan","year":"2018","unstructured":"Pan X, Yan E, Cui M, Hua W. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J informetrics. 2018;12:481\u201393. https:\/\/doi.org\/10.1016\/j.joi.2018.03.005.","journal-title":"J informetrics"},{"key":"2181_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002095","author":"J Tian","year":"2024","unstructured":"Tian J, Dong YX, Wang L, Wu YM, Zhao ZY, Che GW. Mapping the evolution of 3D printing in cardio-thoracic diseases: a global bibliometric analysis. Int J Surg. 2024. https:\/\/doi.org\/10.1097\/JS9.0000000000002095.","journal-title":"Int J Surg"},{"issue":"8","key":"2181_CR20","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1097\/JS9.0000000000000468","volume":"109","author":"G Chen","year":"2023","unstructured":"Chen G, Jin S, Xia Q, Wang Z, Shi Z, Chen G, et al. Insight into the history and trends of surgical simulation training in education: a bibliometric analysis. Int J Surg. 2023;109(8):2204\u201313. https:\/\/doi.org\/10.1097\/JS9.0000000000000468.","journal-title":"Int J Surg"},{"issue":"2","key":"2181_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jnci\/90.2.150","volume":"90","author":"WH Chow","year":"1998","unstructured":"Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90(2):150\u20135. https:\/\/doi.org\/10.1093\/jnci\/90.2.150.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2181_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.7326\/0003-4819-130-11-199906010-00003","volume":"130","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstr\u00f6m R, Nyr\u00e9n O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883\u201390. https:\/\/doi.org\/10.7326\/0003-4819-130-11-199906010-00003.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2181_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstr\u00f6m R, Lindgren A, Nyr\u00e9n O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825\u201331. https:\/\/doi.org\/10.1056\/NEJM199903183401101.","journal-title":"N Engl J Med"},{"issue":"8","key":"2181_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794\u20138. https:\/\/doi.org\/10.1056\/NEJMsr1606602.","journal-title":"N Engl J Med"},{"issue":"11","key":"2181_CR25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399-1412.e7. https:\/\/doi.org\/10.1016\/j.cgh.2013.05.009.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2181_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199\u2013211. https:\/\/doi.org\/10.7326\/0003-4819-143-3-200508020-00006.","journal-title":"Ann Intern Med"},{"issue":"17","key":"2181_CR27","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625\u201338. https:\/\/doi.org\/10.1056\/NEJMoa021423.","journal-title":"N Engl J Med"},{"issue":"9612","key":"2181_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(08)60269-X.","journal-title":"Lancet"},{"issue":"5","key":"2181_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/1055-9965.EPI-05-0860","volume":"15","author":"A Kubo","year":"2006","unstructured":"Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0860.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2181_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2007.04.046","volume":"133","author":"DA Corley","year":"2007","unstructured":"Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al. Abdominal obesity and body mass index as risk factors for Barrett\u2019s esophagus. Gastroenterology. 2007;133(1):34\u201341. https:\/\/doi.org\/10.1053\/j.gastro.2007.04.046.","journal-title":"Gastroenterology"},{"issue":"3","key":"2181_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamasurg.2022.6998","volume":"158","author":"A Lazzati","year":"2023","unstructured":"Lazzati A, Poghosyan T, Touati M, Collet D, Gronnier C. Risk of esophageal and gastric cancer after bariatric surgery. JAMA Surg. 2023;158(3):264\u201371. https:\/\/doi.org\/10.1001\/jamasurg.2022.6998.","journal-title":"JAMA Surg"},{"issue":"4","key":"2181_CR32","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/ijms24043316","volume":"24","author":"V Rai","year":"2023","unstructured":"Rai V, Abdo J, Agrawal DK. Biomarkers for early detection, prognosis, and therapeutics of esophageal cancers. Int J Mol Sci. 2023;24(4):3316. https:\/\/doi.org\/10.3390\/ijms24043316.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2181_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13098-021-00627-6","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu H, Wang R. Metabolic syndrome and esophageal cancer risk: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):8. https:\/\/doi.org\/10.1186\/s13098-021-00627-6.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"2181_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00535-019-01648-9","volume":"55","author":"JH Cho","year":"2020","unstructured":"Cho JH, Shin CM, Han KD, Yoon H, Park YS, Kim N, et al. Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea. J Gastroenterol. 2020;55(3):307\u201316. https:\/\/doi.org\/10.1007\/s00535-019-01648-9.","journal-title":"J Gastroenterol"},{"issue":"5","key":"2181_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00125-003-1109-5","volume":"46","author":"CK Chang","year":"2003","unstructured":"Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia. 2003;46(5):595\u2013607. https:\/\/doi.org\/10.1007\/s00125-003-1109-5.","journal-title":"Diabetologia"},{"issue":"6","key":"2181_CR36","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325. https:\/\/doi.org\/10.2337\/diabetes.54.6.1615.","journal-title":"Diabetes"},{"issue":"9491","key":"2181_CR37","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. IDF epidemiology task force consensus group. Lancet. 2005;366(9491):1059\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(05)67402-8.","journal-title":"Lancet"},{"issue":"1","key":"2181_CR38","doi-asserted-by":"publisher","first-page":"10291","DOI":"10.1038\/s41598-020-67329-3","volume":"10","author":"JH Seo","year":"2020","unstructured":"Seo JH, Kim YD, Park CS, Han KD, Joo YH. Hypertension is associated with oral, laryngeal, and esophageal cancer: a nationwide population-based study. Sci Rep. 2020;10(1):10291. https:\/\/doi.org\/10.1038\/s41598-020-67329-3.","journal-title":"Sci Rep"},{"issue":"10","key":"2181_CR39","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/ijc.28334","volume":"134","author":"A Milan","year":"2014","unstructured":"Milan A, Puglisi E, Ferrari L, Bruno G, Losano I, Veglio F. Arterial hypertension and cancer. Int J Cancer. 2014;134(10):2269\u201377. https:\/\/doi.org\/10.1002\/ijc.28334.","journal-title":"Int J Cancer"},{"issue":"4","key":"2181_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","volume":"59","author":"T Stocks","year":"2012","unstructured":"Stocks T, Van Hemelrijck M, Manjer J, Bj\u00f8rge T, Ulmer H, Hallmans G, et al. Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and Cancer Project. Hypertension. 2012;59(4):802\u201310. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.189258.","journal-title":"Hypertension"},{"issue":"7","key":"2181_CR41","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/sj.bjc.6602490","volume":"92","author":"JP Fryzek","year":"2005","unstructured":"Fryzek JP, Poulsen AH, Johnsen SP, McLaughlin JK, S\u00f8rensen HT, Friis S. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer. 2005;92(7):1302\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6602490.","journal-title":"Br J Cancer"},{"issue":"12","key":"2181_CR42","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/1055-9965.EPI-22-0703","volume":"31","author":"JE Lee","year":"2022","unstructured":"Lee JE, Han K, Yoo J, Yeo Y, Cho IY, Cho B, et al. Association between metabolic syndrome and risk of esophageal cancer: a nationwide population-based study. Cancer Epidemiol Biomarkers Prev. 2022;31(12):2228\u201336. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-0703.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2181_CR43","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s11010-021-04067-8","volume":"476","author":"ILP Beales","year":"2021","unstructured":"Beales ILP, Ogunwobi OO. Leptin activates Akt in oesophageal cancer cells via multiple atorvastatin-sensitive small GTPases. Mol Cell Biochem. 2021;476(6):2307\u201316. https:\/\/doi.org\/10.1007\/s11010-021-04067-8.","journal-title":"Mol Cell Biochem"},{"issue":"25","key":"2181_CR44","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.2174\/0929867325666180713154505","volume":"26","author":"T Tzanavari","year":"2019","unstructured":"Tzanavari T, Tasoulas J, Vakaki C, Mihailidou C, Tsourouflis G, Theocharis S. The role of adipokines in the establishment and progression of head and neck neoplasms. Curr Med Chem. 2019;26(25):4726\u201348. https:\/\/doi.org\/10.2174\/0929867325666180713154505.","journal-title":"Curr Med Chem"},{"issue":"2","key":"2181_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cyto.2010.05.006","volume":"51","author":"D Diakowska","year":"2010","unstructured":"Diakowska D, Krzystek-Korpacka M, Markocka-Maczka K, Diakowski W, Matusiewicz M, Grabowski K. Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract. Cytokine. 2010;51(2):132\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2010.05.006.","journal-title":"Cytokine"},{"issue":"1\u20132","key":"2181_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mce.2008.01.023","volume":"285","author":"OO Ogunwobi","year":"2008","unstructured":"Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol. 2008;285(1\u20132):43\u201350. https:\/\/doi.org\/10.1016\/j.mce.2008.01.023.","journal-title":"Mol Cell Endocrinol"},{"key":"2181_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2018.03.039","volume":"425","author":"WW Xu","year":"2018","unstructured":"Xu WW, Li B, Zhao JF, Yang JG, Li JQ, Tsao SW, et al. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness. Cancer Lett. 2018;425:88\u2013100. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.039.","journal-title":"Cancer Lett"},{"issue":"7","key":"2181_CR48","first-page":"2827","volume":"32","author":"XH Bao","year":"2012","unstructured":"Bao XH, Takaoka M, Hao HF, Wang ZG, Fukazawa T, Yamatsuji T, et al. Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity. Anticancer Res. 2012;32(7):2827\u201334.","journal-title":"Anticancer Res"},{"issue":"1","key":"2181_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13046-023-02623-2","volume":"42","author":"K Fang","year":"2023","unstructured":"Fang K, Sun M, Leng Z, Chu Y, Zhao Z, Li Z, et al. Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia. J Exp Clin Cancer Res. 2023;42(1):73. https:\/\/doi.org\/10.1186\/s13046-023-02623-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2181_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42. https:\/\/doi.org\/10.1186\/s13073-016-0303-2.","journal-title":"Genome Med"},{"key":"2181_CR51","doi-asserted-by":"publisher","first-page":"791274","DOI":"10.3389\/fmicb.2021.791274","volume":"12","author":"W Dan","year":"2022","unstructured":"Dan W, Peng L, Yan B, Li Z, Pan F. Human microbiota in esophageal adenocarcinoma: pathogenesis, diagnosis prognosis and therapeutic implications. Front Microbiol. 2022;12:791274. https:\/\/doi.org\/10.3389\/fmicb.2021.791274.","journal-title":"Front Microbiol"},{"issue":"10","key":"2181_CR52","doi-asserted-by":"publisher","first-page":"fiw161","DOI":"10.1093\/femsec\/fiw161","volume":"92","author":"NO Kaakoush","year":"2016","unstructured":"Kaakoush NO, Morris MJ. The oesophageal microbiome: an unexplored link in obesity-associated oesophageal adenocarcinoma. FEMS Microbiol Ecol. 2016;92(10):fiw161. https:\/\/doi.org\/10.1093\/femsec\/fiw161.","journal-title":"FEMS Microbiol Ecol"},{"issue":"7541","key":"2181_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature14232","volume":"519","author":"B Chassaing","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92\u20136. https:\/\/doi.org\/10.1038\/nature14232.","journal-title":"Nature"},{"issue":"3","key":"2181_CR54","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11695-019-03708-8","volume":"29","author":"P Janse","year":"2019","unstructured":"Janse P, Nafteux P, Lannoo M, Steger PH, Sirbu F. Esophageal squamous cell carcinoma after adjustable gastric banding. Obes Surg. 2019;29(3):1083\u20135. https:\/\/doi.org\/10.1007\/s11695-019-03708-8.","journal-title":"Obes Surg"},{"issue":"2","key":"2181_CR55","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s11695-018-3576-2","volume":"29","author":"P Gehwolf","year":"2019","unstructured":"Gehwolf P, Kienzl-Wagner K, Cakar-Beck F, Sch\u00e4fer A, Wykypiel H. Laparoscopic adjustable gastric banding: an underestimated risk factor for the development of esophageal cancer?-a nationwide survey. Obes Surg. 2019;29(2):626\u201331. https:\/\/doi.org\/10.1007\/s11695-018-3576-2.","journal-title":"Obes Surg"},{"issue":"5","key":"2181_CR56","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/SLA.0b013e3182879ded","volume":"257","author":"AM Carlin","year":"2013","unstructured":"Carlin AM, Zeni TM, English WJ, Hawasli AA, Genaw JA, Krause KR, et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg. 2013;257(5):791\u20137. https:\/\/doi.org\/10.1097\/SLA.0b013e3182879ded.","journal-title":"Ann Surg"},{"issue":"4","key":"2181_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s11695-017-2952-7","volume":"28","author":"D Froylich","year":"2018","unstructured":"Froylich D, Abramovich-Segal T, Pascal G, Haskins I, Appel B, Kafri N, et al. Long-term (over 10 Years) retrospective follow-up of laparoscopic adjustable gastric banding. Obes Surg. 2018;28(4):976\u201380. https:\/\/doi.org\/10.1007\/s11695-017-2952-7.","journal-title":"Obes Surg"},{"issue":"11","key":"2181_CR58","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.soard.2020.06.016","volume":"16","author":"LA Bevilacqua","year":"2020","unstructured":"Bevilacqua LA, Obeid NR, Yang J, Zhu C, Altieri MS, Spaniolas K, et al. Incidence of GERD, esophagitis, Barrett\u2019s esophagus, and esophageal adenocarcinoma after bariatric surgery. Surg Obes Relat Dis. 2020;16(11):1828\u201336. https:\/\/doi.org\/10.1016\/j.soard.2020.06.016.","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"2181_CR59","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00268-012-1582-4","volume":"36","author":"B Kayani","year":"2012","unstructured":"Kayani B, Okabayashi K, Ashrafian H, Harling L, Rao C, Darzi A, et al. Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis. World J Surg. 2012;36(8):1785\u201395. https:\/\/doi.org\/10.1007\/s00268-012-1582-4.","journal-title":"World J Surg"},{"issue":"1","key":"2181_CR60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12876-020-01267-2","volume":"20","author":"M Karimian","year":"2020","unstructured":"Karimian M, Salamati M, Azami M. The relationship between metabolic syndrome and increased risk of Barrett\u2019s esophagus: an updated systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):138. https:\/\/doi.org\/10.1186\/s12876-020-01267-2.","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"2181_CR61","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1002\/hep4.2073","volume":"6","author":"S McHenry","year":"2022","unstructured":"McHenry S, Zong X, Shi M, Fritz CDL, Pedersen KS, Peterson LR, et al. Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers. Hepatol Commun. 2022;6(12):3299\u2013310. https:\/\/doi.org\/10.1002\/hep4.2073.","journal-title":"Hepatol Commun"},{"issue":"11","key":"2181_CR62","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15(11):1224\u201335. https:\/\/doi.org\/10.1016\/S1470-2045(14)70420-6.","journal-title":"Lancet Oncol"},{"issue":"9911","key":"2181_CR63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","volume":"383","author":"CS Fuchs","year":"2014","unstructured":"Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, REGARD Trial Investigators, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383(9911):31\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(13)61719-5.","journal-title":"Lancet"},{"key":"2181_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001.","journal-title":"Metabolism"},{"key":"2181_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j477","volume":"356","author":"M Kyrgiou","year":"2017","unstructured":"Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356: j477. https:\/\/doi.org\/10.1136\/bmj.j477.","journal-title":"BMJ"},{"issue":"39","key":"2181_CR66","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","volume":"66","author":"CB Steele","year":"2017","unstructured":"Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, et al. Vital signs: trends in incidence of cancers associated with overweight and obesity\u2014United States, 2005\u20132014. MMWR Morb Mortal Wkly Rep. 2017;66(39):1052\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6639e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2181_CR67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","volume":"154","author":"HG Coleman","year":"2018","unstructured":"Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):390\u2013405. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.046.","journal-title":"Gastroenterology"},{"issue":"5","key":"2181_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v6.i5.112","volume":"6","author":"KJ Napier","year":"2014","unstructured":"Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112\u201320. https:\/\/doi.org\/10.4251\/wjgo.v6.i5.112.","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"2181_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers15020485","volume":"15","author":"S Pati","year":"2023","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers. 2023;15(2):485. https:\/\/doi.org\/10.3390\/cancers15020485.","journal-title":"Cancers"},{"issue":"11","key":"2181_CR70","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/cac2.12220","volume":"41","author":"L Lu","year":"2021","unstructured":"Lu L, Mullins CS, Schafmayer C, Zei\u00dfig S, Linnebacher M. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun. 2021;41(11):1137\u201351. https:\/\/doi.org\/10.1002\/cac2.12220.","journal-title":"Cancer Commun"},{"issue":"8","key":"2181_CR71","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41416-020-1012-6","volume":"123","author":"Z Cao","year":"2020","unstructured":"Cao Z, Zheng X, Yang H, Li S, Xu F, Yang X, et al. Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study. Br J Cancer. 2020;123(8):1336\u201344. https:\/\/doi.org\/10.1038\/s41416-020-1012-6.","journal-title":"Br J Cancer"},{"issue":"24","key":"2181_CR72","doi-asserted-by":"publisher","first-page":"00955","DOI":"10.1016\/j.soard.2024.12.002","volume":"S1550\u20137289","author":"A Lazzati","year":"2024","unstructured":"Lazzati A, Poghosyan T, Goro S, Gronnier C. Risk assessment for esophageal cancer after bariatric surgery: a comparative cohort study between sleeve gastrectomy and gastric bypass. Surg Obes Relat Dis. 2024;S1550\u20137289(24):00955\u20139. https:\/\/doi.org\/10.1016\/j.soard.2024.12.002.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"2181_CR73","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1038\/s41598-018-28268-2","volume":"8","author":"B Liu","year":"2018","unstructured":"Liu B, Cheng B, Wang C, Chen P, Cheng Y. The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma. Sci Rep. 2018;8(1):10101. https:\/\/doi.org\/10.1038\/s41598-018-28268-2.","journal-title":"Sci Rep"},{"issue":"3","key":"2181_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10120-024-01477-7","volume":"27","author":"SY Nam","year":"2024","unstructured":"Nam SY, Jo J, Jeon SW. Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort. Gastric Cancer. 2024;27(3):451\u201360. https:\/\/doi.org\/10.1007\/s10120-024-01477-7.","journal-title":"Gastric Cancer"},{"issue":"5","key":"2181_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.419","volume":"11","author":"J Lv","year":"2021","unstructured":"Lv J, Wang J, Shen X, Liu J, Zhao D, Wei M, et al. A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma. Clin Transl Med. 2021;11(5): e419. https:\/\/doi.org\/10.1002\/ctm2.419.","journal-title":"Clin Transl Med"},{"issue":"5","key":"2181_CR76","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jrsm.1729","volume":"15","author":"M Gusenbauer","year":"2024","unstructured":"Gusenbauer M. Beyond google scholar, Scopus, and Web of Science: an evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices. Res Synth Methods. 2024;15(5):802\u201317. https:\/\/doi.org\/10.1002\/jrsm.1729.","journal-title":"Res Synth Methods"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02181-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:47:23Z","timestamp":1743259643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02181-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2181"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02181-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was needed because this is not a human study, but only online information was used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}